Mitochondria: a target for cancer therapy

被引:203
|
作者
Armstrong, JS [1 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Fac Med, Dept Biochem, Singapore 117597, Singapore
关键词
mitochondria; apoptosis; Bcl-2; Bax; BH3; domain; cancer; mitochondrial membrane permeabilization; mitochondrial permeability transition; reactive oxygen species; cyclosporine A; mitochondrial membrane potential;
D O I
10.1038/sj.bjp.0706556
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mitochondria, the cells powerhouses, are essential for maintaining cell life, and they also play a major role in regulating cell death, which occurs upon permeabilization of their membranes. Once mitochondrial membrane permeabilization (MMP) occurs, cells die either by apoptosis or necrosis. Key factors regulating MMP include calcium, the cellular redox status ( including levels of reactive oxygen species) and the mobilization and targeting to mitochondria of Bcl-2 family members. Contemporary approaches to targeting mitochondria in cancer therapy use strategies that either modulate the action of Bcl-2 family members at the mitochondrial outer membrane or use specific agents that target the mitochondrial inner membrane and the mitochondrial permeability transition (PT) pore. The aim of this review is to describe the major mechanisms regulating MMP and to discuss, with examples, mitochondrial targeting strategies for potential use in cancer therapy.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 50 条
  • [31] Spermidine as a target for cancer therapy
    Fan, Jingjing
    Feng, Ziyuan
    Chen, Ning
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [32] Apoptosis: Target of cancer therapy
    Ferreira, CG
    Epping, M
    Kruyt, FAE
    Giaccone, G
    CLINICAL CANCER RESEARCH, 2002, 8 (07) : 2024 - 2034
  • [33] Angiogenesis as a target for cancer therapy
    Kaban, K
    Herbst, RS
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (05) : 1125 - +
  • [34] mTOR as a target for cancer therapy
    Houghton, Peter J.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 2 - 2
  • [35] The proteasome as a target for cancer therapy
    Voorhees, PM
    Dees, EC
    O'Neil, B
    Orlowski, RZ
    CLINICAL CANCER RESEARCH, 2003, 9 (17) : 6316 - 6325
  • [36] EpCAM As a Target in Cancer Therapy
    Gires, Olivier
    Bauerle, Patrick A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15) : E239 - E240
  • [37] Glutaminolysis as a target for cancer therapy
    Jin, L.
    Alesi, G. N.
    Kang, S.
    ONCOGENE, 2016, 35 (28) : 3619 - 3625
  • [38] Missing the target in cancer therapy
    Jacob J. Adashek
    Alexey Goloubev
    Shumei Kato
    Razelle Kurzrock
    Nature Cancer, 2021, 2 : 369 - 371
  • [39] Ras as a target in cancer therapy
    Midgley, RS
    Kerr, DJ
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 (02) : 109 - 120
  • [40] Microbiome as a Target for Cancer Therapy
    Suraya, Ratoe
    Nagano, Tatsuya
    Kobayashi, Kazuyuki
    Nishimura, Yoshihiro
    INTEGRATIVE CANCER THERAPIES, 2020, 19